Differential aerobic exercise‐induced changes in plasma aldosterone between African Americans and Caucasians
- 17 August 2007
- journal article
- research article
- Published by Wiley in Experimental Physiology
- Vol. 92 (5) , 871-879
Abstract
The H+-electrochemical gradient was originally considered as a driving force for solute transport only across cellular membranes of bacteria, plants and yeast. However, in the mammalian small intestine, a H+-electrochemical gradient is present at the epithelial brush-border membrane in the form of an acid microclimate. Over recent years, a large number of H+-coupled cotransport mechanisms have been identified at the luminal membrane of the mammalian small intestine. These transporters are responsible for the initial stage in absorption of a remarkable variety of essential and non-essential nutrients and micronutrients, including protein digestion products (di/tripeptides and amino acids), vitamins, short-chain fatty acids and divalent metal ions. Proton-coupled cotransporters expressed at the mammalian small intestinal brush-border membrane include: the di/tripeptide transporter PepT1 (SLC15A1); the proton-coupled amino-acid transporter PAT1 (SLC36A1); the divalent metal transporter DMT1 (SLC11A2); the organic anion transporting polypeptide OATP2B1 (SLC02B1); the monocarboxylate transporter MCT1 (SLC16A1); the proton-coupled folate transporter PCFT (SLC46A1); the sodium–glucose linked cotransporter SGLT1 (SLC5A1); and the excitatory amino acid carrier EAAC1 (SLC1A1). Emerging research demonstrates that the optimal intestinal absorptive capacity of certain H+-coupled cotransporters (PepT1 and PAT1) is dependent upon function of the brush-border Na+–H+ exchanger NHE3 (SLC9A3). The high oral bioavailability of a large number of pharmaceutical compounds results, in part, from absorptive transport via the same H+-coupled cotransporters. Drugs undergoing H+-coupled cotransport across the intestinal brush-border membrane include those used to treat bacterial infections, hypercholesterolaemia, hypertension, hyperglycaemia, viral infections, allergies, epilepsy, schizophrenia, rheumatoid arthritis and cancer.Keywords
This publication has 45 references indexed in Scilit:
- Hyperaldosteronism and HypertensionHypertension, 2005
- Weight Loss and the Renin-Angiotensin-Aldosterone SystemHypertension, 2005
- Racial differences in potassium disposalKidney International, 2004
- Endothelium-Derived Nitric Oxide Modulates Vascular Action of Aldosterone in Renal ArterioleHypertension, 2004
- Rapid Nongenomic Effects of Aldosterone on Human Forearm VasculatureHypertension, 2003
- Regulation of aldosterone secretion in hypertensive blacks.Hypertension, 1994
- Effect of regular exercise on 24-hour arterial pressure in older hypertensive humans.Hypertension, 1991
- Racial Differences in Aldosterone Excretion and Plasma Aldosterone Concentrations in ChildrenNew England Journal of Medicine, 1989
- Neural control of renal function: cardiovascular implications.Hypertension, 1989
- Blood pressure and hormonal responses to aerobic exercise.Hypertension, 1985